{
 "context": "The following article called 'Swiss Stocks Decline as Syngenta, Roche Fall; ABB Shares Rise in Zurich' was published on 2010-07-23. The body of the article is as follows:\n    \nStocks in Switzerland fell as a\nslide in  Syngenta AG  and Roche Holding AG offset gains in ABB\nLtd. as investors waited for the results of stress tests of 91\nEuropean banks.  \n Syngenta fell 1.9 percent after it was downgraded by\nVontobel Holding AG. Roche and Novartis each fell more than 1\npercent. ABB rose 1.4 percent after the stock was upgraded at\nSociete Generale SA. Financial shares slipped ahead of a report\nthat will show which banks need more capital.  \n The benchmark  Swiss Market Index  fell 0.4 percent to\n6,168.65 at 12:11 a.m. in Zurich, on course to end the week down\n0.3 percent. The SMI has retreated 12 percent from this year\u2019s\nhigh on April 15 amid speculation that Europe\u2019s debt crisis may\nderail the economic recovery and concern that Chinese\nauthorities are cooling their nation\u2019s rate of growth. The\nbroader  Swiss Performance Index  slipped 0.2 percent today.  \n European banking regulators will publish stress tests from\n6 p.m. Brussels time today. The regulators have assessed whether\nthe banks have enough capital, defined as a Tier 1 ratio of at\nleast 6 percent, to withstand a recession and a sovereign-debt\ncrisis, according to a document from the Committee of European\nBanking Supervisors. Lenders that fail the tests will have to\nraise additional capital.  \n Syngenta Falls  \n Syngenta fell 1.9 percent to 225 francs, extending\nyesterday\u2019s 5.3 percent loss after it was downgraded to \u201chold\u201d\nfrom \u201cbuy\u201d at Vontobel.  \n \u201cPricing is likely to remain in negative territory in the\ncoming quarters and margins will hence be under pressure,\u201d\n Patrick Rafaisz , an analyst at Vontobel Equity Research, said in\na note to clients today. \u201cThe tailwind from lower raw materials\nprices is receding at a time when Opex is on the rise. We fail\nto identify any short-term triggers.\u201d  \n Roche , the world\u2019s biggest maker of cancer drugs, slipped\n1.7 percent to 136.1 francs, erasing its 1 percent gain\nyesterday after it reported a 58 percent increase in first-half\nnet income.  \n Novartis AG , the maker of the Diovan hypertension drug,\ndropped 1.1 percent to 51.25 francs, erasing yesterday\u2019s 1.1\npercent climb.  \n ABB gained 1.4 percent to 20.77 francs, rising for the\nthird day. The world\u2019s largest builder of electricity networks\nwas upgraded to \u201chold\u201d from \u201csell\u201d at Societe Generale.  \n UBS AG , the Swiss bank, slumped 0.6 percent to 15.41\nfrancs, its first loss in four days.  \n To contact the reporter responsible for this story:\n Adam Ewing  in Stockholm at \n aewing5@bloomberg.net .\n\n    The day before the article was published, the stock price of UBS AG was 9.44972038269043 and the day after the article was published, the stock price of UBS AG was ",
 "expected": "9.582549095153809",
 "date": "2010-07-23",
 "ticker": "UBS",
 "company": "UBS AG",
 "url": "http://www.bloomberg.com/news/2010-07-23/swiss-stocks-decline-as-syngenta-roche-fall-abb-shares-rise-in-zurich.html"
}